Clinical Trials Logo

Intervertebral Disc Degeneration clinical trials

View clinical trials related to Intervertebral Disc Degeneration.

Filter by:
  • Enrolling by invitation  
  • Page 1 ·  Next »

NCT ID: NCT05972616 Enrolling by invitation - Clinical trials for Degenerative Disc Disease

Natural Matrix Protein™ (NMP™) in Interbody Lumbar Fusion

Start date: August 2023
Phase:
Study type: Observational

The objective of this study is to evaluate the performance of Induce Biologics NMP™ when used to promote interbody fusion for degenerative disease of the lumbar spine.

NCT ID: NCT05944081 Enrolling by invitation - Clinical trials for Degenerative Disc Disease

Postmarket Clinical Follow-Up Study on Arcadius XP L® Interbody Fusion Device

ARREST
Start date: March 15, 2024
Phase:
Study type: Observational

The purpose of this study is to collect clinical and radiological mid-term (min. 1 year) data on the ArcadiusXP L® lumbar stand-alone cage in a post-market clinical follow-up study (PMCF) limited to 60 patients.

NCT ID: NCT05812092 Enrolling by invitation - Clinical trials for Cervical Radiculopathy

Treatment of One and/or Two Level Cervical Degenerative Disc Disease

Start date: May 1, 2021
Phase:
Study type: Observational

The objective of this study is to collect clinical and radiographic outcomes using the CONDUIT™ Interbody Cervical System with supplemental fixation using a DePuy Synthes Cervical Plating System.

NCT ID: NCT05745129 Enrolling by invitation - Low Back Pain Clinical Trials

Applying Artificial Intelligence in Developing Personalized and Sustainable Healthcare for Spinal Disorders

AID-Spine
Start date: December 1, 2021
Phase:
Study type: Observational

The primary objective is to use machine learning methods on large survey and health register data to identify participants with different treatment trajectories and health outcomes after surgical and/or conservative treatment for spinal disorders. Secondary objectives are to 1) conduct external validation of the prediction models, and 2) explore how the prediction models can be implemented into AI-based clinical co-decision tools and interventions.

NCT ID: NCT05691231 Enrolling by invitation - Clinical trials for Degenerative Disc Disease

Long-Term Assessment of the Safety and Performance of the NuVasive Simplify Disc at Two Levels

Start date: January 18, 2023
Phase:
Study type: Observational

A prospective, multicenter post-market clinical follow-up study to evaluate the 10-year long-term safety and effectiveness of the Simplify Disc at two levels in subjects who were enrolled in the IDE study (NCT03123549) and/or post approval study (NCT04980378).

NCT ID: NCT05536453 Enrolling by invitation - Clinical trials for Degenerative Disc Disease (DDD)

Retro Comparison of Subsidence Following Interbody Devices in Lumbar Spine

Start date: August 16, 2022
Phase:
Study type: Observational

The objective of this retrospective study is an investigational clinical follow-up, of patients treated with interbody fusion devices (IBFD), both expandable (EXP) and static (STC), according to their intended use and cleared labeling to understand IBFD design and technique characteristics that affect occurrence rates of subsidence. Patients treated with IBFD's (both EXP and STC) according to their intended use and cleared labeling 1. EXP IBFD's that expand in width and height demonstrate reduced occurrence of subsidence post-operatively when compared to EXP IBFD's that expand in height only and STC IBFD's. 2. EXP IBFD's that are comprised of multi-material composition with Polyetheretherketone (PEEK) endplate contacting surfaces demonstrate reduced occurrence of subsidence on post-operative radiographs when compared to EXP and STC IBFD's that are primarily comprised of Ti with Ti endplate contacting surfaces. 3. achieve radiographic fusion at a rate consistent with the state-of-the-art 4. achieve significant improvements in pain and function compared to baseline 5. experience adverse events at a frequency comparable to reported rates for TLIF or PLIF surgery 6. not demonstrate any intraoperative complications during the implant process 7. operative approach does not correlate with increased rates of subsidence

NCT ID: NCT05258435 Enrolling by invitation - Clinical trials for Degenerative Disc Disease

Long-term Assessment of the Safety and Performance of the NuVasive Simplify Disc

Start date: February 9, 2022
Phase:
Study type: Observational

A prospective, multicenter post-market clinical follow-up study to evaluate the 10-year long-term safety and effectiveness of the Simplify Disc in subjects who were enrolled in the post approval study (NCT04630626).

NCT ID: NCT05110833 Enrolling by invitation - Spinal Stenosis Clinical Trials

Dose Responsiveness as a Measure of Clinical Effectiveness During Neuromonitored Spine Surgery

IONM
Start date: May 1, 2020
Phase:
Study type: Observational

Intraoperative Neuromonitoring (IONM) is a tool used by neurophysiologists during spine surgery to prevent irreversible damage to the spinal cord during procedures through a system of alerts. This study investigates the effectiveness of IONM in 300 participants receiving spine surgery. The goal of this study is to refine the alert criteria for procedures in which IONM is used.

NCT ID: NCT05098431 Enrolling by invitation - Spinal Stenosis Clinical Trials

Comparison of Three Approaches of Electrode Placement to Detect Changes in Motor Evoked Potentials During Spine Surgery

Start date: July 1, 2022
Phase: N/A
Study type: Interventional

Motor Evoked Potentials are an aspect of intraoperative neuromonitoring, a tool used by neurophysiologists during surgery to prevent irreversible damage to the spinal cord during procedures. This study investigates the utility of three separate quadriceps MEP recording approaches over a total of 40 limbs (20 participants).

NCT ID: NCT05011474 Enrolling by invitation - Clinical trials for Patients With Chronic Low Back Pain Due to Degenerative Lumbar Disc

Safety and Efficacy Study of Matrilin-3 Pretreated Autologous Adipose Derived Mesenchymal Stem Cells Implantation in Chronic Low Back Pain Patients With Lumbar Intervertebral Disc Degeneration

MANT3_ASC
Start date: April 23, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

To investigate the safety and efficacy of autologous adipose-derived mesenchymal stem cell spheroids pretreated with matrillin-3 in chronic low back pain patients with lumbar intervertebral disc degeneration.